NFKB1 and breast cancer: For example, Di Huang et al. [7] found that NF-κB-interacting lncRNA (NKILA) increased T cell sensitivity to activation-induced cell death (AICD) by inhibiting NF-κB, which promoted immune evasion in breast cancer.